[1] DIMOU L, SIMONS M. Diversity of oligodendrocytes and their progenitors. Curr Opin Neurobiol. 2017;47:73-79.
[2] BOSHANS LL, SHERAFAT A, NISHIYAMA A. The effects of developmental and current niches on oligodendrocyte precursor dynamics and fate. Neurosci Lett. 2020;715:134593.
[3] NISHIYAMA A, BOSHANS L, GONCALVES CM, et al. Lineage, fate, and fate potential of NG2-glia. Brain Res. 2016;1638(Pt B):116-128.
[4] 马雪霞.人少突胶质前体细胞体外分化及体内成髓鞘研究[D].广州:南方医科大学,2019.
[5] DOMINGUES HS, CRUZ A, CHAN JR, et al. Mechanical plasticity during oligodendrocyte differentiation and myelination. Glia. 2018;66(1):5-14.
[6] BUSER JR, MAIRE J, RIDDLE A, et al. Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol. 2012;71(1):93-109.
[7] BACK SA, LUO NL, BORENSTEIN NS, et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci. 2001;21(4):1302-1312.
[8] BACK SA. White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol. 2017;134(3):331-349.
[9] CHEN LX, MA SM, ZHANG P, et al. Neuroprotective effects of oligodendrocyte progenitor cell transplantation in premature rat brain following hypoxic-ischemic injury. PLoS One. 2015;10(3):e0115997.
[10] PIAO J, MAJOR T, AUYEUNG G, et al. Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell. 2015;16(2):198-210.
[11] XU L, RYU J, HIEL H, et al. Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiation. Stem Cell Res Ther. 2015;6(1):93.
[12] KIM TK, PARK D, BAN YH, et al. Improvement by Human Oligodendrocyte Progenitor Cells of Neurobehavioral Disorders in an Experimental Model of Neonatal Periventricular Leukomalacia. Cell Transplant. 2018;27(7):
1168-1177.
[13] SKAPER SD. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases. Prog Brain Res. 2019;245:119-144.
[14] RODRIGUES GMC, GAJ T, ADIL MM, et al. Defined and Scalable Differentiation of Human Oligodendrocyte Precursors from Pluripotent Stem Cells in a 3D Culture System. Stem Cell Reports. 2017;8(6):1770-1783.
[15] LI L, TIAN E, CHEN X, et al. GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. Cell Stem Cell. 2018;23(2):239-251.e6.
[16] YAMASHITA T, MIYAMOTO Y, BANDO Y, et al. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells. PLoS One. 2017;12(2): e0171947.
[17] CUI QL, D’ABATE L, FANG J, et al. Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate. Stem Cells Dev. 2012;21(11):1831-1837.
[18] CHOI EH, XU Y, MEDYNETS M, et al. Activated T cells induce proliferation of oligodendrocyte progenitor cells via release of vascular endothelial cell growth factor-A. Glia. 2018;66(11):2503-2513.
[19] WANG L, SCHLAGAL CR, GAO J, et al. Oligodendrocyte differentiation from human neural stem cells: A novel role for c-Src. Neurochem Int. 2018;120:21-32.
[20] LU Y, YANG Y, WANG Z, et al. Isolation and culture of human oligodendrocyte precursor cells from neurospheres. Brain Res Bull. 2015;118:17-24.
[21] 汪兆艳,杨印祥,王倩,等.不同保存介质对人少突胶质前体细胞生物学特性的影响[J].中国组织工程研究,2019, 23(29): 4651-4655.
[22] WELLIVER RR, POLANCO JJ, SEIDMAN RA, et al. Muscarinic Receptor M3R Signaling Prevents Efficient Remyelination by Human and Mouse Oligodendrocyte Progenitor Cells. J Neurosci. 2018;38(31):6921-6932.
[23] NEUMANN B, KAZANIS I. Oligodendrocyte progenitor cells: the ever mitotic cells of the CNS. Front Biosci (Schol Ed). 2016;8:29-43.
[24] ESPINOSA-JEFFREY A, BLANCHI B, BIANCOTTI JC, et al. Efficient Generation of Viral and Integration-Free Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes. Curr Protoc Stem Cell Biol. 2016; 38:2D.18.1-2D.18.27.
[25] DULAMEA AO. The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies. Neural Regen Res. 2017;12(12):1939-1944.
[26] SUO N, GUO YE, HE B, et al. Inhibition of MAPK/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases. Glia. 2019;67(7):1320-1332.
[27] ALMEIDA RG, LYONS DA. On Myelinated Axon Plasticity and Neuronal Circuit Formation and Function. J Neurosci. 2017;37(42):10023-10034.
[28] NGUYEN LH, ONG W, WANG K, et al. Effects of miR-219/miR-338 on microglia and astrocyte behaviors and astrocyte-oligodendrocyte precursor cell interactions. Neural Regen Res. 2020;15(4):739-747.
[29] DOUVARAS P, WANG J, ZIMMER M, et al. Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. Stem Cell Reports. 2014;3(2):250-259.
[30] ALL AH, GHARIBANI P, GUPTA S, et al. Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors. PLoS One. 2015;10(1):e0116933.
[31] SYPECKA J, ZIEMKA-NALECZ M, DRAGUN-SZYMCZAK P, et al. A simple, xeno-free method for oligodendrocyte generation from human neural stem cells derived from umbilical cord: engagement of gelatinases in cell commitment and differentiation. J Tissue Eng Regen Med. 2017; 11(5):1442-1455.
[32] WANG C, LUAN Z, YANG Y, et al. High purity of human oligodendrocyte progenitor cells obtained from neural stem cells: suitable for clinical application. J Neurosci Methods. 2015;240:61-66.
[33] MATSUSHITA T, AMAGAI Y, SOGA T, et al. A novel oligodendrocyte cell line OLP6 shows the successive stages of oligodendrocyte development: late progenitor, immature and mature stages. Neuroscience. 2005; 136(1):
115-121.
[34] FUMAGALLI M, DANIELE S, LECCA D, et al. Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation. J Biol Chem. 2011;286(12):10593-10604.
[35] CUI QL, FRAGOSO G, MIRON VE, et al. Response of human oligodendrocyte progenitors to growth factors and axon signals. J Neuropathol Exp Neurol. 2010;69(9):930-944.
[36] HAYASHI C, SUZUKI N. Heterogeneity of Oligodendrocytes and Their Precursor Cells. Adv Exp Med Biol. 2019;1190:53-62.
|